FDA Warning Letter - Critical cGMP Failures at Granules India Ltd | Key Learnings for Professionals
In this video, we analyze the FDA warning letter issued to Granules India Limited on February 26, 2025, highlighting serious CGMP violations including cleaning failures, poor facility maintenance, equipment issues, and data integrity breaches.
👉 Whether you're a QA professional, regulatory affairs specialist, or a pharma student—this breakdown provides actionable insights into:
Why proper cleaning validation is essential
How inadequate HVAC systems can cause contamination
What poor data practices mean for compliance
What FDA expects in your CAPA responses
🎯 Learn from this real-world case study and strengthen your pharmaceutical manufacturing and quality systems to stay GMP-compliant and audit-ready.
📌 Don’t forget to subscribe to PharmaGuideline for weekly videos on GMP, audits, validation, and FDA inspections.
#FDAWarningLetter #PharmaCompliance #GMPFailures #PharmaQuality #GranulesIndia #CGMP #FDAInspection #PharmaTraining #DataIntegrity #CleaningValidation #PharmaGuideline
Boost Your Pharma Knowledge with Our Exclusive Courses! 🚀📚
Explore our in-depth courses designed for pharmaceutical professionals and students. Gain industry-relevant skills, stay compliant with regulations, and advance your career with expert-led training.
📌 Featured Courses:
• CAPA Management Course
• Analytical Method Validation Course
• GMP Course
💡 Join our Membership to get exclusive access to premium content, industry insights, and priority support!
/ @pharmaguideline
To Get a Certificate Enroll on our website - https://courses.pharmaguideline.com
📢 Stay ahead in the pharma industry—subscribe to our channel for regular updates!
#PharmaceuticalCourses #GMPTraining #CAPA #MethodValidation #PharmaCareers #QualityAssurance #regulatorycompliance
Related Topics:
FDA warning letter 2025
Granules India warning letter
GMP violations India
CGMP non-compliance
FDA inspection findings
cleaning validation
HVAC in pharma
data integrity pharma
pharmaceutical QA
pharma compliance training
pharma regulatory
quality assurance pharma
GMP case study
CAPA pharmaceutical
FDA audit failures
FDA 483 explanation
pharma industry India
pharma manufacturing GMP
warning letter case study
pharma quality systems